Polaryx Therapeutics, Inc. Common Stock ROE

The ROE as of November 2026 (TTM) for Polaryx Therapeutics, Inc. Common Stock (PLYX) is -117.61%

According to Polaryx Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -117.61%. This represents a change of 169.46% compared to the average of -43.65% of the last 4 quarters.

Polaryx Therapeutics, Inc. Common Stock (PLYX) Historical ROE (quarterly & annually)

How has PLYX ROE performed in the past?

The mean historical ROE of Polaryx Therapeutics, Inc. Common Stock over the last ten years is -378.99%. The current -117.61% ROE has changed -68.97% with respect to the historical average. Over the past ten years (40 quarters), PLYX's ROE was at its highest in in the June 2024 quarter at 0%. The ROE was at its lowest in in the March 2024 quarter at -2162.10%.

Polaryx Therapeutics, Inc. Common Stock (PLYX) ROE by Quarter and Year

Discovering the peaks and valleys of Polaryx Therapeutics, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Polaryx Therapeutics, Inc. Common Stock (PLYX) Average ROE

How has PLYX ROE performed in the past?

The current ROE of Polaryx Therapeutics, Inc. Common Stock (PLYX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Polaryx Therapeutics, Inc. Common Stock (PLYX) ROE vs. Peers

How is PLYX’s ROE compared to its peers?

Polaryx Therapeutics, Inc. Common Stock’s ROE is greater than AN2 Therapeutics, Inc. (-53.52%), greater than Crescent Biopharma, Inc. (-97.77%), less than Foghorn Therapeutics Inc. (72.64%), greater than HCW Biologics Inc. (-142.16%), greater than Jade Biosciences, Inc. (-49.11%), greater than Kalaris Therapeutics Inc (-71.71%), greater than Kezar Life Sciences, Inc. (-58.35%), greater than Lyell Immunopharma, Inc. (-91.62%), greater than NextCure, Inc. (-175.46%), greater than Pelthos Therapeutics Inc. (-218.94%),

Build a custom stock screener for Polaryx Therapeutics, Inc. Common Stock (PLYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Polaryx Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Polaryx Therapeutics, Inc. Common Stock (PLYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Polaryx Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.